REFERENCES
- Ballenger JC, Burrows GD, DuPont RL, Lesser IM, Noyes R, Pecknold JC, Rifkin A, Swinson RP: Alpra-zolam in panic disorders and agoraphobia: Results from a multicenter trial: Efficacy in short-term treat-ment. Arch Gen Psychiatry 45:413–422, 1988
- Chouinard G, Annable L, Fontaine R, Solyom L: Al-prazolam in the treatment of generalized anxiety and panic disorders: A double-blind, placebo-controlled study. Psychopharmacology 77:229–233, 1982
- Dunner DL, Dean I, Avery DH, Wilson LG, Hyde TS: Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorders: A controlled study. J Clin Psychiatry 47:458–460, 1986
- Zitrin CM, Klein DF, Woerner MG, Ross DC: Treat-ment of phobias-1. Comparison of imipramine hy-drochloride and placebo. Arch Gen Psychiatry 40:125-138, 1983
- Dager SR, Khan A, Cowley D, Avery DH, Elder J, Roy-Byrne P, Dunner D: Characteristics of placebo response during long-term treatment of panic disor-der. Psychopharmacol Bull 26(3):273–278, 1990
- Fyer AJ, Liebowitz MR, Gorman JM, et al: Discontin-uation of alprazolam treatment in panic patients. Am J Psychiatry 144:303–308, 1987
- Noyes R, Garvey MJ, Cook B, Suelzer M: Controlled discontinuation of benzodiazepine treatment for pa-tients with panic disorder. Am J Psychiatry 148:517–523, 1991
- Clark DB, Taylor CB, Roth WT, Hayward C, Ehlers A, Margraf J, Agras WS: Surreptitious drug use by patients in a panic disorder study. Am J Psychiatry 147:507–509, 1990
- Hamilton M: The assessment of anxiety states by rat-ing. Br J Med Psychol 32:50–55, 1959
- Hamilton M: Development of a rating scale for pri-mary depressive illness. Br J Soc Clin Psychol 6:278–296, 1967
- Marks IM, Mathews AM: Brief standard self-rating for phobic patients. Behav Res Ther 17:263–267, 1979
- National Institute of Mental Health. Special feature: Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychophar-macol Bull 21(4), 1985
- Roy-Bryne P. Dager SR, Cowley DS, Vitaliano P, Dun-ner DL: Relapse and rebound following discontinua-tion of benzodiazepine treatment of panic attacks: Alprazolam versus diazepam. Am J Psychiatry 146(7):860–865, 1989
- Greenblatt DJ, Ochs HR, Lloyd BL: Entry of diazepam and its major metabolite into cerebrospinal fluid. Psy-chopharmacology 70:89–93, 1980
- Dager SR, Cowley DS, Dunner DL: Biological markers in panic states: Lactate-induced panic and mitral valve prolapse. Biol Psychiatry 22:339–359, 1987